J. Narayanan

1.3k total citations · 2 hit papers
22 papers, 803 citations indexed

About

J. Narayanan is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, J. Narayanan has authored 22 papers receiving a total of 803 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in J. Narayanan's work include Diabetic Foot Ulcer Assessment and Management (2 papers), Wound Healing and Treatments (2 papers) and Phytochemicals and Antioxidant Activities (2 papers). J. Narayanan is often cited by papers focused on Diabetic Foot Ulcer Assessment and Management (2 papers), Wound Healing and Treatments (2 papers) and Phytochemicals and Antioxidant Activities (2 papers). J. Narayanan collaborates with scholars based in India, Malaysia and Saudi Arabia. J. Narayanan's co-authors include Manimaran Vasanthan, Patrik Viktor, Renzon Daniel Cosme Pecho, Ahmed Ismail, Devendra Pratap Rao, L. Natrayan, Roxana Yolanda Castillo-Acobo, Tamilanban Thamaraikani, Mabrouk A. Abo‐Zaid and Ali H. Amin and has published in prestigious journals such as Scientific Reports, Neuroscience and Frontiers in Immunology.

In The Last Decade

J. Narayanan

18 papers receiving 789 citations

Hit Papers

Progressing nanotechnology to improve targeted cancer tre... 2023 2026 2024 2025 2023 2023 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation
    2023 552 citations Mohammad Chehelgerdi, Matin Chehelgerdi et al. Molecular Cancer profile →
  2. Exploring the contribution of pro-inflammatory cytokines to impaired wound healing in diabetes
    2023 100 citations J. Narayanan, T. Tamilanban et al. Frontiers in Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Narayanan India 7 275 259 246 119 91 22 803
Shaoping Yin China 14 326 1.2× 243 0.9× 254 1.0× 68 0.6× 54 0.6× 26 768
Paras Famta India 18 329 1.2× 262 1.0× 324 1.3× 53 0.4× 93 1.0× 62 863
Haishi Qiao China 17 178 0.6× 278 1.1× 266 1.1× 87 0.7× 95 1.0× 35 752
Chang Su China 22 424 1.5× 225 0.9× 536 2.2× 112 0.9× 137 1.5× 43 1.2k
Shreya Thakkar India 13 432 1.6× 309 1.2× 230 0.9× 111 0.9× 67 0.7× 28 962
Mohsen Alipour Iran 16 183 0.7× 151 0.6× 392 1.6× 115 1.0× 77 0.8× 30 759
Cuiyan Han China 16 284 1.0× 194 0.7× 273 1.1× 109 0.9× 57 0.6× 42 734
Jilai Tian China 16 155 0.6× 201 0.8× 245 1.0× 78 0.7× 102 1.1× 32 720
Kaushik Kuche India 19 389 1.4× 267 1.0× 424 1.7× 125 1.1× 132 1.5× 41 1.1k

Countries citing papers authored by J. Narayanan

Since Specialization
Citations

This map shows the geographic impact of J. Narayanan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Narayanan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Narayanan more than expected).

Fields of papers citing papers by J. Narayanan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Narayanan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Narayanan. The network helps show where J. Narayanan may publish in the future.

Co-authorship network of co-authors of J. Narayanan

This figure shows the co-authorship network connecting the top 25 collaborators of J. Narayanan. A scholar is included among the top collaborators of J. Narayanan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Narayanan. J. Narayanan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Narayanan, J., et al.. (2025). Role of T cells and cytokines in the pathogenesis of rheumatoid arthritis. Biochemistry and Biophysics Reports. 44. 102278–102278.
2.
3.
Narayanan, J., et al.. (2024). A Review on the Role of SNCA Gene in Neurodegenerative Diseases. Cureus. 16(9). e69450–e69450. 4 indexed citations
4.
Narayanan, J., et al.. (2024). Unleashing light's healing power: an overview of photobiomodulation for Alzheimer's treatment. Future Science OA. 10(1). FSO922–FSO922. 1 indexed citations
5.
6.
7.
Aldahish, Afaf, Rajalakshimi Vasudevan, Taha Alqahtani, et al.. (2024). Silk Fibroin Nanofibers: Advancements in Bioactive Dressings through Electrospinning Technology for Diabetic Wound Healing. Pharmaceuticals. 17(10). 1305–1305. 16 indexed citations
8.
Narayanan, J., et al.. (2024). Computational profiling and pharmacokinetic modelling of Febuxostat: Evaluating its potential as a therapeutic agent for diabetic wound healing. Biochimica et Biophysica Acta (BBA) - General Subjects. 1869(1). 130735–130735. 5 indexed citations
9.
10.
Narayanan, J., Ramasamy Thilagavathi, Muthuramalingam Prakash, et al.. (2024). Dual Anti-Inflammatory and Anticancer Activity of Novel 1,5-Diaryl Pyrazole Derivatives: Molecular Modeling, Synthesis, In Vitro Activity, and Dynamics Study. Biomedicines. 12(4). 788–788. 8 indexed citations
11.
Chehelgerdi, Mohammad, Matin Chehelgerdi, Omer Qutaiba B. Allela, et al.. (2023). Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation. Molecular Cancer. 22(1). 169–169. 552 indexed citations breakdown →
12.
Vasanthan, Manimaran, T. Tamilanban, J. Narayanan, et al.. (2023). Nanogels as novel drug nanocarriers for CNS drug delivery. Frontiers in Molecular Biosciences. 10. 1232109–1232109. 68 indexed citations
13.
Narayanan, J., T. Tamilanban, Ajay Guru, et al.. (2023). Role and mechanistic actions of protein kinase inhibitors as an effective drug target for cancer and COVID. Archives of Microbiology. 205(6). 238–238. 6 indexed citations
14.
Narayanan, J., T. Tamilanban, Vetriselvan Subramaniyan, et al.. (2023). Exploring the contribution of pro-inflammatory cytokines to impaired wound healing in diabetes. Frontiers in Immunology. 14. 1216321–1216321. 100 indexed citations breakdown →
15.
Narayanan, J., et al.. (2023). A DHCP Based Approach To IP Address Management And Allocation In A Network Using VLSM. 882–887. 1 indexed citations
16.
Tamilanban, T., V. Chitra, Vetriselvan Subramaniyan, et al.. (2023). Anti-obesity effects of olivetol in adult zebrafish model induced by short-term high-fat diet. Scientific Reports. 13(1). 18449–18449. 13 indexed citations
17.
Li, Guangyao, Muhammad Rizwan Javed, Mostafa A. Abdel-Maksoud, et al.. (2023). A pan-cancer analysis of HAVCR1 with a focus on diagnostic, prognostic and immunological roles in human cancers.. PubMed. 15(3). 1590–1606. 5 indexed citations
18.
Vasanthan, Manimaran, et al.. (2020). Nanoemulsions: A Better Approach for Antidiabetic Drug Delivery. Current Diabetes Reviews. 17(4). 486–495. 3 indexed citations
19.
Tamilanban, T., et al.. (2020). In silico Molecular docking of Luteolin from Momordica charantia for dementia in Alzheimer's disease. Research Journal of Pharmacy and Technology. 13(5). 2381–2381. 4 indexed citations
20.
Chitra, V., et al.. (2017). Evaluation of In-vitro Antioxidant Activity of Ethanolic Extract of Ugli Fruit. Research Journal of Pharmacy and Technology. 10(11). 3826–3826. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shaoping Yin Breakdown of academic impact, for papers by Paras Famta Breakdown of academic impact, for papers by Haishi Qiao Breakdown of academic impact, for papers by Chang Su Breakdown of academic impact, for papers by Shreya Thakkar Breakdown of academic impact, for papers by Mohsen Alipour Breakdown of academic impact, for papers by Cuiyan Han Breakdown of academic impact, for papers by Jilai Tian Breakdown of academic impact, for papers by Kaushik Kuche
Rankless by CCL
2026